Homeenergy

energy

biotech

Base to Base biotech podcast 57: Keeping drugs cool, and treatment resistant depression

Jim Cornall - May 1, 2026

biotech

ELREXFIO improves progression-free survival for patients with relapsed or refractory multiple myeloma

Jim Cornall - April 30, 2026

biotech

Aragen launches India’s first women-led chemistry synthesis laboratory

Jim Cornall - April 30, 2026

biotech

Vaccine strategy induces broadly neutralising HIV antibodies

Jim Cornall - April 30, 2026

energy

Accelerating battery research with robots

Jim Cornall - September 14, 2023

energy

Sustainable lithium from geothermal power plants

Jim Cornall - September 12, 2023

energy

Rechargeable batteries of the future?

Jim Cornall - August 29, 2023

energy

Lithuanian invention at the forefront of solar technology breakthrough

Jim Cornall - August 27, 2023

energy

Carnot batteries as energy storage of the future

Jim Cornall - July 18, 2023

energy

ReCatalyst closes oversubscribed seed financing round

Jim Cornall - July 18, 2023

1...3 45Page 5 of 5

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Base to Base biotech podcast 57: Keeping drugs cool, and treatment resistant depression

Jim Cornall - May 1, 2026 0

This week, our conversations are with Uwe Diegel, CEO of Lifeina, about their cooling technologies, and with Dirk Beher, CEO of FundaMental Pharma, about...

ELREXFIO improves progression-free survival for patients with relapsed or refractory multiple myeloma

biotech Jim Cornall - April 30, 2026 0

Aragen launches India’s first women-led chemistry synthesis laboratory

biotech Jim Cornall - April 30, 2026 0

Vaccine strategy induces broadly neutralising HIV antibodies

biotech Jim Cornall - April 30, 2026 0

New target for cancer treatment

biotech Jim Cornall - April 29, 2026 0